Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$64K Sell
2,476
-85,573
-97% -$2.32M 0.3% 109
2020
Q2
$3.49M Buy
+88,049
New +$2.44M 2.47% 2
2019
Q4
$546K Buy
12,863
+2,457
+24% +$101K 0.29% 201
2019
Q3
$463K Buy
10,406
+2,686
+35% +$116K 0.3% 24
2019
Q2
$349K Buy
+7,720
New +$345K 0.28% 150
2019
Q1
Sell
-5,236
Closed -$188K 446
2018
Q4
$188K Buy
+5,236
New +$214K 0.13% 300
2018
Q2
Sell
-1,587
Closed -$66K 416
2018
Q1
$66K Sell
1,587
-86,462
-98% -$3.66M 0.08% 382
2017
Q4
$3.49M Buy
+88,049
New +$3.52M 2.47% 2

Other funds holding AVT

Cerebellum's AVT Position: Q3 2020 in Review

Cerebellum reduced its Avnet (AVT) stake by 97% in Q3 2020, selling an estimated $2.32M and leaving 2,476 shares worth $64K. The position accounts for 0.3% of the portfolio, ranked #109.

Cerebellum first reported a position in AVT in Q4 2017 and has held it in 8 quarters since. The position peaked at $3.49M in Q2 2020. 273 funds tracked by Wall St. Rank hold AVT as of Q3 2020.

  • Cerebellum held 2,476 shares of Avnet worth $64K as of Q3 2020.
  • Cerebellum sold 85,573 Avnet shares in Q3 2020, an estimated $2.32M.
  • Avnet made up 0.3% of Cerebellum's portfolio in Q3 2020, its #109 holding.
  • Cerebellum first reported a position in Avnet in Q4 2017 and has held it in 8 quarters since.
  • Cerebellum's Avnet position peaked at $3.49M in Q2 2020.
  • 273 funds tracked by Wall St. Rank held Avnet as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.